Advertisement
U.S. markets open in 5 hours 18 minutes
  • S&P Futures

    5,305.75
    -2.50 (-0.05%)
     
  • Dow Futures

    40,100.00
    -44.00 (-0.11%)
     
  • Nasdaq Futures

    18,511.25
    +7.50 (+0.04%)
     
  • Russell 2000 Futures

    2,133.70
    -4.70 (-0.22%)
     
  • Crude Oil

    81.81
    +0.46 (+0.57%)
     
  • Gold

    2,213.10
    +0.40 (+0.02%)
     
  • Silver

    24.57
    -0.18 (-0.74%)
     
  • EUR/USD

    1.0794
    -0.0035 (-0.32%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.95
    +0.17 (+1.33%)
     
  • GBP/USD

    1.2610
    -0.0028 (-0.22%)
     
  • USD/JPY

    151.3990
    +0.1530 (+0.10%)
     
  • Bitcoin USD

    70,540.13
    +644.81 (+0.92%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,931.98
    0.00 (0.00%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Vitamin Shoppe, Fossil, Akorn are big movers

Vitamin Shoppe, Fossil, Akorn, Aruba Networks are big market movers on Tuesday

NEW YORK (AP) -- Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:

NYSE

Vitamin Shoppe Inc., down $4.08 at $45.23

The vitamins seller revised its full-year forecast for revenue at stores open a year, citing weaker-than-expected April sales.

Regis Corp., up 4 cents at $18.93

The hair salon operator, owner of Supercuts and MasterCuts, posted a fiscal third-quarter profit versus a loss a year ago.

Molson Coors Brewing Co., down 25 cents at $50.72

The brewer said its net income dropped 55 percent during the first quarter, as it invested more in its beer brands.

Nasdaq

Akorn Inc., down $1.13 at $14.02

The generic drugmaker's first quarter results missed Wall Street expectations. It also cut its forecast for 2013 earnings and revenue.

Fossil Inc., up $8.92 at $107.88

Thanks to stronger sales, the maker of watches and handbags said its earnings rose 24 percent during the first quarter.

Ariad Pharmaceuticals Inc., up 20 cents at $17.55

The drugmaker said revenue from its leukemia pill Iclusig, its first approved drug, surpassed Wall Street's expectations.

The Pantry Inc., down $1.57 at $13.27

The convenience store operator said its fiscal second-quarter loss narrowed, but the results missed Wall Street's estimates.

Aruba Networks Inc., down $5.03 at $17.02

The wireless communications company nearly halved its third-quarter adjusted profit expectations and cut its outlook for revenue.

Advertisement